Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | ||||
| Net Income | 171,000 | 271,000 | N/A | 90,000 |
| Depreciation Amortization | 376,000 | 333,000 | N/A | 278,000 |
| Income taxes - deferred | 73,000 | 215,000 | N/A | -73,000 |
| Accounts receivable | 68,000 | -114,000 | N/A | -134,000 |
| Other Working Capital | -177,000 | -225,000 | N/A | -70,000 |
| Other Operating Activity | -192,000 | -139,000 | 0 | -121,000 |
| Operating Cash Flow | $319,000 | $341,000 | $N/A | $-30,000 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -160,000 | 179,000 | N/A | 2,293,000 |
| Net Acquisitions | N/A | -128,000 | N/A | -120,000 |
| Purchase Of Investment | -6,000 | 3,000 | N/A | N/A |
| Other Investing Activity | 64,000 | -871,000 | 0 | -349,000 |
| Investing Cash Flow | $-102,000 | $-817,000 | $N/A | $1,824,000 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 192,000 | 2,758,000 | N/A | 600,000 |
| Debt Repayment | -45,000 | -2,320,000 | N/A | -1,432,000 |
| Common Stock Issued | 2,000 | 4,000 | N/A | 2,000 |
| Dividend Paid | N/A | N/A | N/A | -22,000 |
| Other Financing Activity | -1,000 | -9,000 | 0 | -21,000 |
| Financing Cash Flow | $148,000 | $433,000 | $N/A | $-873,000 |
| Beginning Cash Position | 328,000 | 371,000 | N/A | 628,000 |
| End Cash Position | 693,000 | 328,000 | N/A | 1,549,000 |
| Net Cash Flow | $365,000 | $-43,000 | $N/A | $921,000 |
| Free Cash Flow | ||||
| Operating Cash Flow | 319,000 | 341,000 | N/A | -30,000 |
| Capital Expenditure | -611,000 | -379,000 | N/A | -195,000 |
| Free Cash Flow | -292,000 | -38,000 | 0 | -225,000 |